Effects of the Natural β-Carboline Alkaloid Harmine, a Main Constituent of Ayahuasca, in Memory and in the Hippocampus: A Systematic Literature Review of Preclinical Studies
This review (2016) investigated the claim that harmine can have neuroprotective and cognitive-enhancing effects by reviewing animal and cell-based studies. The results point towards an effect and the authors recommend (more) conducting preclinical and human studies.
Authors
- Jamie Hallak
- Rafael dos Santos
Published
Abstract
Harmine is a natural β-carboline alkaloid found in several botanical species, such as the Banisteriopsis caapi vine used in the preparation of the hallucinogenic beverage ayahuasca and the seeds of Syrian rue (Peganum harmala). Preclinical studies suggest that harmine may have neuroprotective and cognitive-enhancing effects, and retrospective/observational investigations of the mental health of long-term ayahuasca users suggest that prolonged use of this harmine-rich hallucinogen is associated with better neuropsychological functioning. Thus, in order to better investigate these possibilities, we performed a systematic literature review of preclinical studies analyzing the effects of harmine on hippocampal neurons and in memory-related behavioral tasks in animal models. We found two studies involving hippocampal cell cultures and nine studies using animal models. Harmine administration was associated with neuroprotective effects such as reduced excitotoxicity, inflammation, and oxidative stress, and increased brain-derived neurotrophic factor (BDNF) levels. Harmine also improved memory/learning in several animal models. These effects seem be mediated by monoamine oxidase or acetylcholinesterase inhibition, upregulation of glutamate transporters, decreases in reactive oxygen species, increases in neurotrophic factors, and anti-inflammatory effects. The neuroprotective and cognitive-enhancing effects of harmine should be further investigated in both preclinical and human studies.
Research Summary of 'Effects of the Natural β-Carboline Alkaloid Harmine, a Main Constituent of Ayahuasca, in Memory and in the Hippocampus: A Systematic Literature Review of Preclinical Studies'
Introduction
Dos Santos and colleagues introduce harmine as a naturally occurring β-carboline found in Banisteriopsis caapi (a principal component of ayahuasca) and in Peganum harmala (Syrian rue). Earlier preclinical work and observational studies in long-term ayahuasca users have suggested neuroprotective and cognitive-enhancing properties for harmine-rich preparations, but it is unclear whether these effects are attributable specifically to harmine, to other constituents, or to combinations of compounds found in those botanical preparations. This paper sets out to synthesise the preclinical evidence by conducting a systematic literature review of studies that examined the effects of harmine on hippocampal biology and on memory- and learning-related behavioural tasks. The review aims to identify what has been reported in cell-culture and animal models regarding harmine's neuroprotective and cognitive effects and to summarise proposed mechanisms that might underlie those effects.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Study Details
- Study Typemeta
- Journal
- Compound
- Topic
- Authors
- APA Citation
dos Santos, R. G., & Hallak, J. E. C. (2017). Effects of the Natural β-Carboline Alkaloid Harmine, a Main Constituent of Ayahuasca, in Memory and in the Hippocampus: A Systematic Literature Review of Preclinical Studies. Journal of Psychoactive Drugs, 49(1), 1-10. https://doi.org/10.1080/02791072.2016.1260189
References (15)
Papers cited by this study that are also in Blossom
Bouso, J. C., Fábregas, J. M., Antonijoan, R. M. et al. · Psychopharmacology (2013)
Bouso, J. C., González, D., Fondevila, S. et al. · PLOS ONE (2012)
Rodríguez-Fornells, A., Ribeiro, S., Sanches, R. F. et al. · European Neuropsychopharmacology (2015)
Doering-Silveira, E., Lopez, E., Grob, C. S. et al. · Journal of Psychoactive Drugs (2005)
Dos Santos, R. G., Osório, F. L., Crippa, J. A. et al. · brazilian Journal of Psychiatry (2016)
Dos Santos, R. G., Osório, F. L., Crippa, J. A. et al. · Therapeutic Advances in Psychopharmacology (2016)
Favaro, V. M., Yonamine, M., Soares, J. C. K. et al. · PLOS ONE (2015)
Frost, D., Meechoovet, B., Wang, T. et al. · PLOS ONE (2011)
McKenna, D., Riba, J. · Current Topics in Behavioral Neurosciences (2016)
Nunes, A. A., Dos Santos, R. G., Osório, F. L. et al. · Journal of Psychoactive Drugs (2016)
Show all 15 referencesShow fewer
Osório, F. L., Sanches, R. F., Macedo, L. et al. · brazilian Journal of Psychiatry (2015)
Samoylenko, V., Rahman, M. M., Tekwani, B. L. et al. · Journal of Ethnopharmacology (2010)
Sanches, R. F., Osório, F. L., Dos Santos, R. G. et al. · Journal of Clinical Psychopharmacology (2016)
Schenberg, E. E., Alexandre, J. F. M., Filev, R. et al. · PLOS ONE (2015)
Schwarz, M. J., Houghton, P. J., Rose, S. et al. · Pharmacology Biochemistry and Behavior (2003)
Cited By (7)
Papers in Blossom that reference this study
Suay, D., Aicher, H. D., Singer, B. et al. · Journal of Psychopharmacology (2025)
Doss, M. K., Kloft, L., Mason, N. L. et al. · Journal of Psychopharmacology (2024)
Fonseca, A. M., Dos Santos, R. G., Santos, F. P. et al. · European Archives of Psychiatry and Clinical Neuroscience (2024)
Alves, C. L., Cury, R. G., Roster, K. et al. · PLOS ONE (2022)
Bouso, J. C., Ona, G., Dos Santos, R. G. et al. · Advances in Experimental Medicine and Biology (2021)
Jiménez-Garrido, D. F., Gómez-Sousa, M., Ona, G. et al. · Scientific Reports (2020)
Dos Santos, R. G., Hallak, J. E. · Neuroscience and Biobehavioral Reviews (2020)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.